Knee osteoarthritis is one of the most common causes of chronic knee pain, stiffness, swelling, and reduced mobility. For many patients, symptoms gradually interfere with walking, exercise, work, travel, and everyday activities.
Traditional treatments can include physical therapy, weight management, anti-inflammatory medications, corticosteroid injections, hyaluronic acid, platelet-rich plasma (PRP), and eventually knee replacement surgery.
Interest in stem cell therapy for knee osteoarthritis has increased because mesenchymal stromal/stem cells, commonly called MSCs, are being studied for their potential effects on inflammation, joint function, pain, and tissue-repair signaling.
For patients considering stem cell therapy in Mexico, it is important to understand what current clinical research actually shows, what remains uncertain, and how regenerative treatments differ from conventional knee treatments.
What Is Knee Osteoarthritis?
Osteoarthritis is not simply the loss of cartilage.
It is a complex degenerative joint condition that can involve:
- Articular cartilage
- Subchondral bone
- Synovial tissue
- Meniscus
- Ligaments
- Muscles surrounding the knee
- Chronic inflammatory signaling within the joint
Common symptoms include:
- Knee pain
- Morning or activity-related stiffness
- Swelling
- Reduced range of motion
- Grinding or clicking
- Difficulty climbing stairs
- Pain when standing or walking
- Reduced ability to exercise
- Progressive limitation of daily activities
Osteoarthritis can range from relatively mild cartilage deterioration to advanced bone-on-bone joint disease.
The severity of the condition is important when evaluating regenerative treatment options.
What Is Stem Cell Therapy for Knee Osteoarthritis?
Most clinical research involving “stem cells” for knee osteoarthritis focuses on mesenchymal stromal cells, or MSCs.
MSCs may be obtained from sources such as:
- Bone marrow
- Adipose tissue
- Umbilical-cord-associated tissue
- Other perinatal tissues
These cells are being studied because they can release growth factors, cytokines, extracellular vesicles, and other biological signals that interact with surrounding tissues.
Current research increasingly suggests that their potential effects may come primarily from signaling and immunomodulation rather than simply transforming into new cartilage.
How Might MSCs Help an Arthritic Knee?
MSCs are being investigated for several possible biological effects.
These include:
- Modulating inflammatory signaling
- Influencing immune-cell activity
- Supporting tissue-repair pathways
- Releasing growth factors
- Producing extracellular vesicles and signaling molecules
- Interacting with cartilage and synovial cells
- Potentially improving the joint environment
These mechanisms provide a scientific reason to study MSC therapy for osteoarthritis.
However, biological potential should not be confused with guaranteed clinical results.
What Does the Current Evidence Show?
Research on MSC therapy for knee osteoarthritis has expanded significantly.
A 2024 systematic review of 25 randomized controlled trials involving 1,048 patients found improvements in pain after MSC treatment compared with viscosupplementation, although the authors emphasized that robust evidence regarding clinical applicability was still limited. (PubMed)
A 2025 systematic review and meta-analysis of randomized controlled trials also reported improvements in pain and functional outcomes in patients receiving MSC therapy for knee osteoarthritis. (PubMed)
More recent 2026 analyses continue to find potential improvements in pain and function, while also emphasizing substantial differences between studies in cell source, dose, preparation, and administration techniques. (PubMed)
Taken together, current research suggests that MSC therapy may help some patients with knee osteoarthritis, particularly with pain and function.
It does not demonstrate that every patient will improve.
Can Stem Cells Regrow Knee Cartilage?
This is one of the most important distinctions for patients.
Some studies have reported imaging changes that may suggest effects on cartilage or other joint structures.
However, clinical research has not established that an MSC injection can reliably recreate normal cartilage or completely reverse advanced osteoarthritis.
Recent randomized-trial analyses continue to show stronger evidence for improvements in symptoms and function than for consistent structural regeneration of cartilage. (PubMed)
Therefore, claims such as:
“Stem cells will regrow your cartilage”
“Stem cells will completely rebuild your knee”
or
“Stem cells will reverse bone-on-bone arthritis”
should be viewed cautiously.
A more accurate discussion focuses on the possibility of reducing symptoms, improving function, and influencing the biological environment within the joint.
Who May Be a Candidate?
Stem cell therapy may be considered for selected patients who continue to experience knee osteoarthritis symptoms despite conservative treatment.
A medical evaluation should consider:
- Degree of osteoarthritis
- Location of cartilage damage
- Knee alignment
- Meniscus condition
- Ligament stability
- Patient age
- Body weight
- Activity level
- Previous knee surgery
- Previous injections
- Overall health
- Treatment goals
Patients with mild or moderate osteoarthritis may have different expectations from someone with severe joint destruction and major deformity.
Stem cell treatment should not automatically be considered an alternative to knee replacement for every patient.
What About Bone-on-Bone Knee Arthritis?
Patients with advanced osteoarthritis often search for:
“stem cell therapy for bone-on-bone knee”
because they hope to avoid knee replacement.
Regenerative treatments may still be discussed in selected advanced cases, but expectations need to be realistic.
When cartilage is extensively destroyed and significant bone changes or deformity are present, a biological injection cannot be assumed to reconstruct the entire joint.
The medical question becomes whether treatment may provide meaningful improvement in pain or function — not whether it can guarantee restoration of a normal knee.
Does the Source of the Stem Cells Matter?
Possibly.
Research has evaluated MSCs derived from several tissue sources.
These products are not necessarily biologically identical.
Differences may involve:
- Growth characteristics
- Secreted signaling molecules
- Immunomodulatory behavior
- Cell viability
- Manufacturing process
- Donor characteristics
- Culture conditions
A 2026 network meta-analysis examining different MSC sources and doses found that the optimal combination remains uncertain and that results vary between treatment strategies. (PubMed)
This is why patients should not choose a treatment solely because one clinic advertises a larger number of cells.
Is More Stem Cells Better?
Not necessarily.
Cell dose remains an active area of research.
Studies have used widely different doses, and there is currently no universally accepted MSC dose for knee osteoarthritis.
A 2025 systematic review evaluating bone-marrow-derived MSC dose and safety found promising clinical results but also highlighted the continuing uncertainty surrounding optimal dosing. (PubMed)
Important factors include:
- Cell viability
- Cell identity
- Cell source
- Processing quality
- Sterility
- Dose
- Administration technique
- Patient selection
“More cells” is not automatically the same as “better treatment.”
Stem Cells vs. PRP for Knee Osteoarthritis
PRP and MSC therapy are different regenerative approaches.
PRP is prepared from the patient's own blood and contains concentrated platelets and signaling molecules.
MSC therapy introduces living stromal cells with more complex biological signaling capabilities.
PRP has a longer history of orthopedic use and is generally simpler to prepare.
MSC therapy is biologically more complex and remains less standardized.
For some patients, PRP may be reasonable.
For others, MSC therapy may be considered.
Some treatment programs may also investigate combining regenerative approaches, although combining treatments does not automatically mean the result will be superior.
Stem Cells vs. Hyaluronic Acid
Hyaluronic acid injections are commonly used to manage knee osteoarthritis symptoms.
Recent randomized-trial meta-analyses have reported better pain and functional outcomes for MSC injections compared with hyaluronic acid in some studies, with similar overall safety profiles during the study periods. (PubMed)
However, treatment choice should not be based on a single comparison.
Cost, disease severity, patient characteristics, evidence quality, risks, and previous treatments should all be considered.
What Are the Potential Risks?
Clinical trials frequently report temporary adverse effects such as:
- Injection-site pain
- Swelling
- Joint stiffness
- Temporary inflammation
- Short-term discomfort
More serious complications are possible if cellular products are improperly manufactured, contaminated, stored incorrectly, or administered without appropriate medical oversight.
Potential risks can include:
- Infection
- Contamination
- Immune reactions
- Abnormal inflammatory responses
- Injection-related complications
- Failure to achieve the expected benefit
The FDA warns that regenerative medicine products marketed for orthopedic conditions can carry significant risks and states that regenerative medicine products are not FDA-approved in the United States for orthopedic conditions including osteoarthritis and knee pain. (U.S. Food and Drug Administration)
Why Do Patients Travel to Mexico for Stem Cell Therapy?
International patients may consider stem cell therapy in Mexico because certain regenerative medicine procedures may be available there under a regulatory framework different from that of the United States.
Mexico has specific regulatory pathways for regenerative medicine establishments.
COFEPRIS currently identifies sanitary-license categories for regenerative medicine facilities, stem-cell collection centers, stem-cell banks, and establishments involved in the extraction, analysis, preservation, preparation, and supply of human cells and tissues. (Gobierno de México)
The COFEPRIS-09-027 process specifically applies to regenerative medicine establishments involved in obtaining, processing, preserving, or applying progenitor/stem cells, tissues, and cells. (Gobierno de México)
Regulatory authorization of a facility, however, should not be interpreted as proof that every treatment offered by that facility has been clinically proven for knee osteoarthritis.
Regulation and clinical evidence are separate questions.
What Should Patients Ask a Stem Cell Clinic in Mexico?
Before undergoing stem cell therapy for knee osteoarthritis, patients should ask:
- What type of cells are being administered?
- What tissue are the cells derived from?
- Are the cells autologous or donor-derived?
- What is the viable cell count?
- How is viability measured?
- How are donors screened?
- What sterility testing is performed?
- Where are the cells processed?
- How are they transported and stored?
- What dose will be administered?
- Why was that dose selected?
- What evidence supports treatment for knee osteoarthritis?
- What are the realistic expected outcomes?
- What are the risks?
- What follow-up is included?
- What regulatory authorization applies to the clinic and laboratory?
A responsible regenerative medicine provider should be able to answer these questions clearly.
How Should Results Be Measured?
Improvement should be evaluated objectively whenever possible.
Depending on the patient, this might include:
- Pain scores
- Walking ability
- Range of motion
- WOMAC functional scores
- Ability to climb stairs
- Exercise tolerance
- Medication use
- Strength
- Quality-of-life measurements
- Follow-up imaging when clinically appropriate
Patients should know how treatment success will be evaluated before treatment begins.
When Might Surgery Still Be Necessary?
Stem cell therapy does not eliminate the need for orthopedic surgery in every patient.
Advanced osteoarthritis involving severe joint-space loss, substantial deformity, instability, or major mechanical problems may eventually require knee replacement.
Regenerative medicine and orthopedic surgery should not automatically be viewed as competing approaches.
The appropriate treatment depends on the condition of the knee and the needs of the individual patient.
Stem Cell Therapy for Knee Osteoarthritis in Mexico: Setting Realistic Expectations
Current research on mesenchymal stromal cells for knee osteoarthritis is encouraging.
Randomized clinical trials and meta-analyses increasingly suggest that MSC injections may improve pain and function for some patients. (PubMed)
At the same time, important questions remain regarding:
- Optimal cell source
- Optimal cell dose
- Best administration method
- Number of treatments
- Long-term durability
- Patient selection
- Structural cartilage regeneration
This is why regenerative treatment should be individualized rather than marketed as a guaranteed cure.
The Bottom Line
Stem cell therapy for knee osteoarthritis is one of the most actively researched applications of regenerative medicine.
Current clinical evidence suggests that mesenchymal stromal/stem cell therapy may reduce knee pain and improve function in some patients.
The evidence is considerably less certain regarding complete cartilage regeneration or reversal of advanced bone-on-bone osteoarthritis.
Patients considering stem cell therapy in Mexico should look beyond advertised cell numbers and focus on the complete treatment process:
cell source, viability, laboratory quality, sterility, medical evaluation, regulatory compliance, scientific evidence, realistic expectations, and follow-up.
The goal should not simply be to receive the largest number of stem cells.
The goal should be to determine whether regenerative therapy is medically appropriate for the individual knee and whether the proposed treatment is supported by reasonable clinical evidence.
If you are considering a NovaCell program, the next step is usually to share your medical history for a preliminary review. A patient coordinator can outline what information is most helpful, what a potential itinerary might look like, and which therapies may or may not be considered in your situation.
The form and contact details below are intended for non-urgent questions about eligibility, logistics, and program structure. They do not replace emergency care or direct consultation with your own physicians.
The form and contact details below are intended for non-urgent questions about eligibility, logistics, and program structure. They do not replace emergency care or direct consultation with your own physicians.
Contact details
Phone (Mexico): +52 999 358 1309
Email: info@stemcelltherapymexico.net
WhatsApp
You can start a WhatsApp chat with a coordinator using this link:
Message us on WhatsApp
Clinic location
Calle 40 Número 272 A, entre 77 y 79
Col. Montes de Amé, CP 97115
Mérida, Yucatán, Mexico
If you are experiencing worrisome or rapidly worsening symptoms, seek local emergency care immediately rather than waiting for a reply from this website.
Phone (Mexico): +52 999 358 1309
Email: info@stemcelltherapymexico.net
You can start a WhatsApp chat with a coordinator using this link:
Message us on WhatsApp
Clinic location
Calle 40 Número 272 A, entre 77 y 79
Col. Montes de Amé, CP 97115
Mérida, Yucatán, Mexico
If you are experiencing worrisome or rapidly worsening symptoms, seek local emergency care immediately rather than waiting for a reply from this website.